Companies · AI / ML
Africa · AI / ML
Diligence memoA one-page analyst read on VitruvianMD — recommendation, valuation, rhythm, risks.→VitruvianMD: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the ai/ml sector profile.
No named principal in this company's public records yet — see all operators below.
VitruvianMD is one of 2067 AI / ML companies tracked from Africa. By capital raised it ranks mid-pack (ahead of 62% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.
OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seed — a round under $1.0M). Valuation is modeled from stage benchmarks scaled by the ai/ml sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 62% of sector peers (real $). Modeled value above 62% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | — | 2021-08-20 | — | — | 45% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
VitruvianMD is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Accord | AI / ML | — | — | — | same sector |
| Acely | AI / ML | — | — | — | same sector |
| Aedilic | AI / ML | — | — | — | same sector |
| Aemon | AI / ML | — | — | — | same sector |
| Affogato AI | AI / ML | — | — | — | same sector |
| Aftercare | AI / ML | — | — | — | same sector |
| Agentic Labs | AI / ML | — | — | — | same sector |
| Ai Aiba | AI / ML | — | — | — | same sector |
Public records name issuer insiders, not the funds in a round — these investor links come from corroborating sources.
| Firm | Round | Confidence |
|---|---|---|
| Verge Healthtech Fund | Pre-Seed | 55% |
See where VitruvianMD sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at VitruvianMD, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.